Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 136Motor Activity 72Fatigue 10Neoplasms 9Obesity 8Lymphedema 8Colorectal Neoplasms 7Cardiotoxicity 7Weight Loss 6Prostatic Neoplasms 5Breast Cancer Lymphedema 5Ovarian Neoplasms 3Breast Cancer Female 3Triple Negative Breast Neoplasms 2Recurrence 2Overweight 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lung Neoplasms 2Insulin Resistance 2Depression 2Breast Diseases 2Breast Cancer Survivors 2Body Weight Changes 2Atherosclerosis 2Arthralgia 2Ventricular Dysfunction, Left 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

bazedoxifene 1Tamoxifen 1Risk Assessment 1Health Communication 1Exercise 1Estrogens, Conjugated (USP) 1Counseling 1College Fraternities and Sororities 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Risk Reduction Behavior × Exercise × Breast × Clear all
NCT03118882 2017-04-19

STIVI

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Phase NA Completed
1,270 enrolled
BreastGastrointestinal

Body Weight Changes, Breast Neoplasms, Colorectal Neoplasms, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡